COMPARISON

Shatavari vs Black Cohosh: Which Fits You?

Shatavari has newer perimenopause trials. Black cohosh has more menopause research, mixed results, and a rare liver-injury warning.

Shatavari vs black cohosh: which bottle earns a place on the counter?

Hot flashes at 2 a.m. can make a $40 supplement feel almost reasonable. That is exactly why this choice needs receipts, not vibes.

Black cohosh is the older, better-studied menopause herb, but its benefit signal is inconsistent and major guidance groups do not recommend it for hot flashes. Shatavari has newer, more directly perimenopause-focused human trials, but the evidence is small, short and extract-specific. Neither deserves a standing ovation. This is a label-and-evidence comparison, not medical advice.

In short

Shatavari is the narrower choice for someone focused on perimenopause symptoms and willing to verify the exact extract. Black cohosh has a larger menopause literature, but not a cleaner benefit story, plus rare serious liver-injury reports and product-identity risk. Shatavari’s long-term safety record is also incomplete, and its hormonal activity makes medical review sensible with hormone-sensitive conditions, pregnancy-related concerns or hormone-altering medicines. Best of all: choosing neither can beat paying monthly for an uncertain supplement.

The decision table

QuestionShatavariBlack cohosh
Main symptom targetBroad perimenopause symptom scores, hot flashes, stress and sleep in newer small trials.Vasomotor symptoms, especially hot flashes, in older trials.
Evidence strengthLimited but more direct for perimenopause. The evidence base is still young.Much larger, but inconsistent. Major guidance groups still say evidence is insufficient.
Best studied formA named, standardized Asparagus racemosus root extract. Milligrams alone are not enough.Extract varies by solvent, plant chemistry and standardization. No single dose transfers cleanly across products.
Safety headlineShort trials found no serious adverse events, but long-term safety and interactions are not well mapped.Rare liver-damage reports, some serious. Causality and product contamination are unresolved.
CostWide range. Ritual’s new one-a-day blend lists at $39 per 30 capsules, or $1.30 a day.Often cheaper, but the cheapest bottle may have weaker identity details.
Best use hereA measured, one-month experiment after extract identity is clear.Usually hard to justify for hot flashes when the liver warning matters to you.

That is a smaller, more relevant evidence base for shatavari. Small is not weak, but it is not settled.

Symptom targets

Shatavari’s strongest case is the period when cycles are shifting. A 2025 double-blind study assigned 80 perimenopausal women to 300 mg of a 13:1 shatavari root extract standardized above 10% total shatavarins, or placebo, for eight weeks. Seventy-three completed it. The extract group improved more on the Menopause Rating Scale, perceived stress and hot-flash frequency. But the study was single-site, short and small. [1]

A separate 2025 multicentre study also found better overall menopausal symptom scores with a standardized shatavari extract. Eight weeks still cannot tell us what happens over a year. [2]

Black cohosh is mainly sold for hot flashes. A 2023 meta-analysis of 22 studies found a small advantage over placebo for hot flashes and overall symptoms, but not anxiety or depression. Products included standalone and combination formulations, making the signal harder to pin to one bottle. [3]

A 2012 Cochrane review of 16 trials and 2,027 women found no significant difference from placebo in hot-flush frequency or overall symptom scores. Studies used different extracts, solvents and doses. [4] The North American Menopause Society says evidence is insufficient and classifies black cohosh as not recommended for vasomotor symptoms. [5]

Decision: shatavari is the more relevant research fit for broad perimenopause symptoms. Black cohosh is a more established name, not a more established effective option.

Evidence and standardization

For shatavari, the experiment was not just “300 mg.” It was a defined extract with an extraction ratio and shatavarin threshold. A 100 mg capsule can be more concentrated, or a different material. If a seller does not identify the extract, the human evidence cannot be handed to that bottle. Our shatavari for perimenopause explainer shows why the root, ratio and marker compounds matter.

Black cohosh has the same problem. The NIH says products vary because the active ingredients are unknown. Trials ranged from 8 to 160 mg daily and used different extracts, with some triterpene glycoside standardization. [4] “Black cohosh 40 mg” is not automatically the trial extract. Our black cohosh for perimenopause explainer puts identity before the front-label dose.

Safety: the liver warning matters

The rare black cohosh liver issue deserves precise language. NCCIH says cases of liver damage, some serious, have been reported with products labeled as black cohosh. It does not claim the herb caused every case. Wrong herbs, unlisted mixtures or contaminants could be responsible. [6]

The NIH lists at least 83 reports of liver injury associated with black cohosh use, while saying causality has not been established. People with liver disorders are advised to avoid it. Abdominal pain, dark urine or jaundice warrant medical advice. [4]

Shatavari does not carry the same liver signal in the small perimenopause trials. That is reassuring, not a clean bill of health. Those trials lasted eight weeks and excluded significant liver, endocrine and other systemic disease. Long-term safety remains incompletely defined. [7]

Ask a clinician first if you are pregnant, breastfeeding, trying to conceive, have a hormone-sensitive condition, use hormone-altering medicines, or take medicines with important liver effects. Severe symptoms or unexplained bleeding need a medical appointment.

Cost and the choose-neither option

Ritual launched its shatavari-led formula at $39 for 30 capsules, equal to $1.30 a day or $468 a year. The company says it is a monthly subscription. The capsule also contains DIM, vitamin B6 and evening primrose oil, so that is not a clean price for shatavari alone. [8] Stand-alone shatavari can cost less. Black cohosh often sells for $15 to $25 for one to three months, but the cheapest bottle may have the weakest identity details.

PeriProof may earn a commission from a verified Ritual link through Impact without changing the price. Before subscribing, choose one symptom to track and set a one-month stop date. A vague plan to “feel better” turns a test into a recurring purchase.

For hot flashes, neither herb offers strong enough guidance to be a default. The 2023 North American Menopause Society statement recommends options such as cognitive behavioral therapy, clinical hypnosis, certain medicines and weight loss when applicable, while not recommending supplements for vasomotor symptoms. [5]

Our decision rule: consider shatavari only if the exact standardized extract is disclosed, your clinician says the safety profile fits, and the purchase has a defined one-month test. Consider black cohosh only after reviewing its liver warning, uncertain efficacy and exact product identity. For most readers seeking a dependable answer to hot flashes, the cleanest default is neither.

Sources

  1. Mahajan et al., randomized shatavari trial in perimenopause, 2025
  2. Gudise et al., multicentre menopausal-symptom trial, 2025
  3. Sadahiro et al., pairwise meta-analysis of black cohosh extracts, 2023
  4. NIH Office of Dietary Supplements: Black Cohosh
  5. The North American Menopause Society: 2023 nonhormone therapy position statement
  6. NCCIH: Black Cohosh—Usefulness and Safety
  7. LactMed: Wild Asparagus
  8. Ritual Perimenopause Health launch release, September 15, 2026